Baker Bros. Advisors LP Athira Pharma, Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 3,153,807 shares of ATHA stock, worth $1.7 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,153,807
Previous 3,153,807
-0.0%
Holding current value
$1.7 Million
Previous $8.64 Million
3.29%
% of portfolio
0.11%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding ATHA
# of Institutions
74Shares Held
22.8MCall Options Held
73.4KPut Options Held
97.8K-
Perceptive Advisors LLC New York, NY5.4MShares$2.92 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$882,5930.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$806,1072.57% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$806,1070.29% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.3MShares$699,9090.02% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $20.4M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...